KR20220073796A - 수명 연장을 위한 조성물 및 방법 - Google Patents

수명 연장을 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20220073796A
KR20220073796A KR1020227014286A KR20227014286A KR20220073796A KR 20220073796 A KR20220073796 A KR 20220073796A KR 1020227014286 A KR1020227014286 A KR 1020227014286A KR 20227014286 A KR20227014286 A KR 20227014286A KR 20220073796 A KR20220073796 A KR 20220073796A
Authority
KR
South Korea
Prior art keywords
elegans
spp
subject
bacterial strain
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227014286A
Other languages
English (en)
Korean (ko)
Inventor
조티 아마라나트 고빈단
엘람파리티 자야마니
프리티 에이치. 채터
Original Assignee
마블바이옴 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마블바이옴 인코포레이티드 filed Critical 마블바이옴 인코포레이티드
Publication of KR20220073796A publication Critical patent/KR20220073796A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/208—Fungi extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/02—Acetobacter
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020227014286A 2019-10-01 2020-09-23 수명 연장을 위한 조성물 및 방법 Ceased KR20220073796A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962909186P 2019-10-01 2019-10-01
US62/909,186 2019-10-01
PCT/US2020/052251 WO2021067100A1 (en) 2019-10-01 2020-09-23 Compositions and methods for extending lifespan

Publications (1)

Publication Number Publication Date
KR20220073796A true KR20220073796A (ko) 2022-06-03

Family

ID=75337328

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227014286A Ceased KR20220073796A (ko) 2019-10-01 2020-09-23 수명 연장을 위한 조성물 및 방법

Country Status (9)

Country Link
US (1) US20220330597A1 (https=)
EP (1) EP4037697A4 (https=)
JP (2) JP7817925B2 (https=)
KR (1) KR20220073796A (https=)
CN (1) CN114555102A (https=)
AU (1) AU2020359357A1 (https=)
CA (1) CA3153779A1 (https=)
IL (2) IL291798B2 (https=)
WO (1) WO2021067100A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114365845B (zh) * 2022-02-18 2023-03-28 吉林大学 一种植物发酵组合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000861A2 (en) * 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
JP2008214215A (ja) * 2007-03-01 2008-09-18 Mitsukan Group Honsha:Kk アポトーシス誘導能を有する組成物
WO2014102588A2 (en) * 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) * 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US10722543B2 (en) * 2016-01-28 2020-07-28 Oxyrase, Inc. Methods for inhibiting tumor growth using anaerobe microorganisms
JP2018131416A (ja) * 2017-02-16 2018-08-23 国立大学法人 鹿児島大学 免疫増強剤及びその製造方法
US11497235B2 (en) * 2017-09-04 2022-11-15 Kewpie Corporation Acetic bacterial cell-containing food composition and method of producing the same
CA3088782A1 (en) * 2018-01-23 2019-08-01 The General Hospital Corporation Compositions and methods for improving mitochondrial function
EP4028558A4 (en) * 2019-09-12 2024-01-03 MarvelBiome, Inc. Compositions and methods for characterizing a microbiome
KR20240113455A (ko) * 2021-09-17 2024-07-22 마블바이옴 인코포레이티드 신경퇴행성 질환을 치료하기 위한 마이크로바이옴 조성물, 성분 또는 대사산물의 방법 및 용도

Also Published As

Publication number Publication date
EP4037697A1 (en) 2022-08-10
CA3153779A1 (en) 2021-04-08
IL291798B2 (en) 2025-10-01
AU2020359357A1 (en) 2022-04-28
CN114555102A (zh) 2022-05-27
IL320580A (en) 2025-07-01
JP2026021466A (ja) 2026-02-10
JP7817925B2 (ja) 2026-02-19
IL291798A (en) 2022-06-01
EP4037697A4 (en) 2024-04-03
WO2021067100A1 (en) 2021-04-08
IL291798B1 (en) 2025-06-01
JP2022551584A (ja) 2022-12-12
US20220330597A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
JP2025115999A (ja) 組成物、及びマイクロバイオームを特性評価するための方法
US20250228277A1 (en) Microbial compositions comprising ellagitannin and methods of use
US9050276B2 (en) Autism-associated biomarkers and uses thereof
McKean et al. The costs of immunity and the evolution of immunological defense mechanisms
JP2026021466A (ja) 寿命を延長するための組成物及び方法
CN116847859A (zh) 微生物组组合物的方法和用途
RU2854523C1 (ru) Композиции и способы для увеличения продолжительности жизни
CN121926964A (zh) 用于延长寿命的组合物和方法
HK40076210A (en) Compositions and methods for extending lifespan
HK40076257A (en) Compositions and methods for characterizing a microbiome
Eeckhaut et al. The butyrate producing Clostridium cluster IV genus Butyricicoccus has a decreased abundance in IBD stool samples and a comparative efficacy in TNBS models compared to currently available therapeutics
EP3456824A1 (en) Obesity-related disease therapeutic agent by hepatic secretory metabolic regulator inhibitory action
Delprete Pathogenetic mechanisms of gastrointestinal symptoms in a mouse model of Fabry disease: insights on the microbiota-gut-brain axis
Klopp Soluble CD14 produced by bovine mammary epithelial cells modulates their response to full length LPS
von Frieling Effects of malnutrition on epithelia-microbe interactions in the intestinal tract of Drosophila melanogaster
CN117320692A (zh) 微生物组组合物、组分或代谢物用于治疗眼睛病症的方法和用途
HK40101818A (zh) 微生物组组合物的方法和用途
Hanuschak Investigating the microbial and immune mechanisms of depressive-like behaviour in a humanized mouse model of MDD
Loos Track 2: From genes and environment to pathophysiology

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601